Thymosin Alpha-1 is a naturally occurring peptide that supports immune system function and has been studied for its effects on various infections and critical illnesses. It is typically administered via subcutaneous injection daily, with a gradual increase in dose over time to assess toleration and achieve optimal immune modulation. The peptide is reconstituted from a lyophilized powder and carefully measured for accurate daily dosing.
- Naturally occurring 28-amino acid peptide from the thymus gland.
- Primarily acts as an immune system modulator, enhancing T-cell function.
- Investigated for chronic viral infections, sepsis, and critical illness.
- Excellent safety profile, with mild injection-site irritation being the most common side effect.
- Dosing involves a gradual titration from 300 mcg to 500 mcg daily.
Reconstitution
Vial strength
5 mg
Bacteriostatic water
3 mL
Concentration
1.67 mg/mL
1 unit = 0.01 mL = 16.7 mcg
- 1Draw 3.0 mL of bacteriostatic water using a sterile syringe.
- 2Carefully inject the water down the side wall of the peptide vial, avoiding direct contact with the powder and preventing foaming.
- 3Gently swirl or roll the vial until the powder is fully dissolved; do not shake vigorously.
- 4Label the vial with the date of reconstitution and store it in the refrigerator between 2–8 °C (35.6–46.4 °F), protected from light.
Dosing schedule
| Phase | Dose | On a U-100 syringe |
|---|---|---|
| Week 1 | 300 mcg | 18 units (0.18 mL) |
| Weeks 2-8 | 500 mcg | 30 units (0.30 mL) |
Protocol detail
| Start | Begin with 300 mcg daily for the first week to assess individual tolerance. |
|---|---|
| Target | Increase to 500 mcg daily from Week 2 onward, continuing for the remainder of the cycle. |
| Frequency | Administer once per day via subcutaneous injection. |
| Cycle Length | Typically 8–12 weeks, with an optional extension up to 16 weeks based on individual needs and goals. |
| Timing | Administer at any consistent time each day, ensuring rotation of injection sites. |
Overview at a glance
| Goal | Support immune modulation and enhance host defense mechanisms. |
|---|---|
| Schedule | Daily subcutaneous injections for 8–12 weeks; can extend to 16 weeks. |
| Dose Range | 300–500 mcg daily, with gradual titration. |
| Reconstitution | 3.0 mL bacteriostatic water per 5 mg vial for a concentration of ~1.67 mg/mL. |
| Storage | Lyophilized powder needs refrigeration or freezing. Reconstituted solution requires refrigeration and should be used within 7 days. |
How it works
Thymosin Alpha-1 (Tα1) is a natural component of the thymus gland that plays a crucial role in immune system regulation. It primarily functions by promoting the development and differentiation of T-cells, which are vital for adaptive immunity. Tα1 also enhances the activity of other immune cells, like dendritic cells, and stimulates the release of essential cytokines such as interferon-α and interleukin-2. These actions collectively strengthen the body's immune response, aiding in the fight against various pathogens and supporting overall immune health. This modulating effect makes Tα1 beneficial for individuals with compromised immunity.
Reported effects
- Enhances T-cell maturation and function
- Modulates immune responses
- Supports host defense mechanisms
- May aid in recovery from chronic infections
- Demonstrates good safety profile
Reported side effects
- Mild injection-site irritation (redness, discomfort)
Storage
Lyophilised (unmixed)
Refrigerate at 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F); minimize moisture exposure.
After reconstitution
Refrigerate at 2–8 °C (35.6–46.4 °F); use within 7 days. Avoid freeze-thaw cycles and protect from light.
Supplies
| Peptide vials | Thymosin Alpha-1 (5 mg each): 6 vials for 8 weeks, 9 for 12 weeks, or 12 for 16 weeks. |
|---|---|
| Insulin Syringes (U-100) | 7 syringes per week (1 per day); 56 for 8 weeks, 84 for 12 weeks, or 112 for 16 weeks. |
| Bacteriostatic Water (10 mL bottles) | ~3.0 mL per vial for reconstitution; 2 bottles for 8-12 weeks, 4 bottles for 16 weeks. |
| Alcohol Swabs | Approximately 2 per day (vial stopper + injection site); 2-3 boxes of 100-count for the protocol duration. |
Important notes
- Always use new, sterile insulin syringes and dispose of them properly in a sharps container.
- Rotate injection sites (e.g., abdomen, thighs, upper arms) to prevent local irritation and promote better absorption.
- Inject the solution slowly and wait a few seconds before withdrawing the needle.
- Keep a record of daily doses and injection sites to ensure consistency and avoid errors.
- Inspect the reconstituted solution for clarity before each use; do not administer if it appears cloudy or discolored.
Frequently asked questions
How quickly will I notice the effects of Thymosin Alpha-1?
The effects of Thymosin Alpha-1, particularly those related to immune modulation, tend to develop gradually. While some individuals might feel improvements within a few weeks, full benefits often become more apparent over several weeks to months as the immune system is supported and optimized.
Can I take Thymosin Alpha-1 with other supplements or medications?
Thymosin Alpha-1 has a generally good safety profile. However, if you are taking other medications or supplements, especially those that affect the immune system, it's always best to consult with a healthcare professional to ensure there are no contraindications or potential interactions.
What happens if I miss a dose of Thymosin Alpha-1?
If you miss a dose of Thymosin Alpha-1, simply resume your regular dosing schedule the next day. Do not double your dose to compensate for the missed one, as consistency over the cycle length is more important than a single missed dose.
Is it safe to extend the cycle length beyond 12 weeks?
While the protocol suggests 8-12 weeks, an optional extension to 16 weeks is mentioned. Clinical studies have shown Tα1 to be well-tolerated for durations up to 6-12 months at various dosages. However, any decision to extend the cycle should be based on individual goals and ideally with professional guidance.
Educational reference only. These figures summarise how Thymosin Alpha-1 is commonly described in research literature and supplier documentation, including the Thymosin Alpha-1 listing at peptidesuk4u.co.uk. They are not a prescription, not medical advice, and not a recommendation to self-administer anything.
Related protocols
Thymosin Alpha-1 (10 mg Vial)
Immune system modulator supporting T-cell function and host defense.
Glutathione (1500 mg Vial)
Master antioxidant supporting detoxification, cellular health, and immune function.
Glutathione (600 mg Vial)
Master antioxidant supporting detoxification, cellular health, and immune function.
Vilon (20 mg Vial)
Immunoregulatory dipeptide supporting immune markers and thymic function.